Skip to main content

LATEST UPDATES: Tracking COVID-19 (coronavirus)

UC San Diego Professor Develops New Way To Monitor TB Patients

— There's a new way to make sure tuberculosis patients are taking their daily dose of medicine. Researchers at UC San Diego have developed a smartphone app that does the trick.

A smart phone app developed at UC San Diego offers a low-cost way to make sure that TB patients are following their treatment regimen.

The infectious disease can be cured with a six-month course of antibiotics but it's not easy getting patients to take their drugs for that long.

To make sure patients stay on track, public health agencies send workers out to watch them take their daily dose of medication. It's called Directly Observed Therapy, or DOT.

UC San Diego's Dr. Richard Garfein invented an application for smartphones that allows patients to video themselves taking their drugs. They then post the video on a secure server where public health workers can watch it.

Garfein was able to develop and test his smartphone-based method with help from San Diego County and the Verizon Foundation.

The video DOT will soon be tried out in New York, San Francisco and London.

Garfein hopes it will be a helpful tool in the fight against TB.

"By lowering the cost of delivering DOT using mobile phones, it lowers the threshold, so in fact, more patients could be put on DOT that currently are not being monitored at all," Garfein explained.

In 2011, TB killed 1.4 million people worldwide.

FEATURED PODCAST

San Diego News Matters podcast branding

KPBS' daily news podcast covering local politics, education, health, environment, the border and more. New episodes are ready weekday mornings so you can listen on your morning commute.

  • Don’t have time to keep up on the latest news? We’ve got you covered with a mid-week check-in every Wednesday afternoon.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Curious San Diego banner

Want more KPBS news?
Find us on Twitter and Facebook, or sign up for our newsletters.

To view PDF documents, Download Acrobat Reader.